Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2006;37:2217
Published online before print August 17, 2006, doi: 10.1161/01.STR.0000237630.41750.c3
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/9/2217    most recent
01.STR.0000237630.41750.c3v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Friedman, E. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Friedman, E. H.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Parkinson's Disease
*Patient Rights
*Vascular Diseases

(Stroke. 2006;37:2217.)
© 2006 American Heart Association, Inc.


Letters to the Editor

Reduced Autonomic Activity in Parkinson Disease Patients

Ernest H. Friedman, MD

Department of Medicine and Psychiatry, Case University, Cleveland, Ohio

To the Editor:

Scigliano et al1 report that reduced risk factors for vascular disorders in Parkinson disease patients may be attributed to reduced autonomic activity, suggesting that autonomic hyperactivity may be involved in the pathogenesis of vascular disorders. Neurobiological features are demonstrated by the association of reduction of blood pressure with longer, less recurrent speech hesitation pauses of &2 seconds. These responses are linked to rhythmic and prefrontal cortical modulation of dopamine, regulating brain stem cardiovascular control and coping behavior. Matching speech hesitation pauses in spontaneous dialogs is a joint, mutually responsive rhythm with prelinguistic origins. These findings support auditory training of small steps to neuroplasticity with a lasting benefit in adults2 and provide precise methods to monitor incremental dopaminergic treatment that Parkinsonians may receive for their disease to prevent a major increase in cerebrovascular disorders.1

References

1. Scigliano G, Musicco M, Soliveri P, Piccolo I, Ronchetti G, Girotti F. Reduced risk factors for vascular disorders in Parkinson disease patients. Stroke. 2006; 37: 1184–1188.[Abstract/Free Full Text]

2. Friedman EH, Finnell DS. Neurobiology and medication adherence. Current Psychiatry. 2005; 4: 11: 3. Letter and response.





This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/9/2217    most recent
01.STR.0000237630.41750.c3v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Friedman, E. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Friedman, E. H.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Parkinson's Disease
*Patient Rights
*Vascular Diseases